Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+18139Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+18894Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+25816Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+25823Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+26551Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+27312Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+27835Peak area normalizedfemale Diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+27877Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+27957Peak area normalizedfemale Diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+31475Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+36486Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+40955Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+41152Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+42246Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+43531Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+48985Peak area normalizedfemale Diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+49451Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+49760Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+51827Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+53744Peak area normalizedfemale Diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+57521Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+61340Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+62917Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+64225Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+76347Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+78757Peak area normalizedmale Diabetic no neuropathy

Return to search page
  logo